FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I):
Formula (I) or a pharmaceutically acceptable salt thereof, where: Z is -O- or -S-; Y is - (CH2)3-NR9R10; R1 is a partially unsaturated or aromatic 5- or 6-membered heterocycle; R2 independently in each case is -F, -Cl, -Br, -CH3 or -CN; R3 independently in each case is -H,- F, -Cl, -Br, -CF3, -OCF3, -CN, (C1-C12)alkyl or (C1-C12)alkoxy; R9 represents (C1-C6)alkyl, (C3-C8)cycloalkyl, pyrazolyl or pyridinyl; here R9 optionally is further substituted with 1 or 2 substituents selected from the group consisting of -COOH, -COOR11, -CONR11R12, -SO2R11, -SO2NR11R12, -OH, -CN, -OR11 and -NR11R12; where R11 and R12 can form a 6-membered heterocycloalkyl ring; R10 is R11, -COR11, -COOR11, -SO2R11, 5-methyl-2-oxo-1,3-dioxol-4-yl, , -COO-CH(CH3)OCOCH(CH3)2; or R9 and R10 together form a piperazinone or 4-8-membered heterocycloalkyl ring, wherein said heterocycloalkyl ring is substituted with 1 or 2 substituents selected from the group consisting of -COOH, -COOR11, -CH2-COOR11, -OH, -NH2, -CN and (C1-C8)alkoxy; R11 and R12 are independently H or (C1-C6)alkyl optionally substituted with 4-8-membered heterocycloalkyl ring; and m and n are each independently 1, 2, 3 or 4 modulating the sodium channels, in particular modulating NaV1.7.
EFFECT: modulators of the sodium channel for the treatment of pain are proposed.
40 cl, 33 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | 2017 |
|
RU2769827C2 |
BIARILE MONOBACTAM COMPOUNDS AND METHODS OF THEIR APPLICATION FOR TREATMENT OF BACTERIAL INFECTIONS | 2016 |
|
RU2746129C2 |
COMPOUNDS OF FORMULA (I) AND FORMULA (A), PHARMACEUTICAL COMPOSITION, MEDICINAL PRODUCT, USE AND METHOD OF OBTAINING COMPOUNDS OF FORMULA (I) | 2018 |
|
RU2822758C2 |
NEW BRAF INHIBITORS AS "PARADOX BREAKERS" | 2020 |
|
RU2825870C1 |
HETEROCYCLIC COMPOUNDS AND METHODS OF APPLICATION | 2009 |
|
RU2525116C2 |
DERIVATIVES OF HETEROARYLCARBAMOYLBENZENE | 2004 |
|
RU2330030C2 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2538965C2 |
ARYLCARBONYL DERIVATIVES AS THERAPEUTIC AGENTS | 2003 |
|
RU2340605C2 |
COMPOUND HAVING AGONISTIC ACTIVITY AGAINST GPR119, METHOD FOR ITS PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS AN EFFECTIVE COMPONENT | 2015 |
|
RU2670197C1 |
Authors
Dates
2018-10-11—Published
2014-03-13—Filed